Infertility: Clinical Trials

19 trials for Infertility, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 terminated. 19 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 419Terminated 19

Follow Infertility: new trials by email Literature Review of Infertility trials Research Report on Infertility

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ibuprofen Versus Ketorolac for Pain Relief During Hysterosalpingogram
Ibuprofen 800 mg oral, Ketorolac 30mg oral - Infertility, Female
Phase 4TerminatedMadigan Army Medical Center122022-03-242024-12-24
Efficacy and Safety of Crinone Versus Combination Medication (ACCESS)
Crinone, Duphaston - Infertility
Phase 4TerminatedMerck KGaA, Darmstadt, Germany1722019-05-312024-03-12
TICON-Day 3, Time Lapse Versus Conventional Method in Day 3 Embryo Culture and Assessment
GERI+ incubator, Conventional incubator - Infertility
Phase 4TerminatedMerck KGaA, Darmstadt, Germany4082018-04-162020-12-02
Clinical Performance and Safety Investigation of ENDOmetrial Washing MEdical DEvice Forielle
Forielle - Infertility
Phase 4TerminatedMerck KGaA, Darmstadt, Germany92018-01-122019-09-24
Random-start Ovarian Stimulation in Egg-donors (ROSE)
Random start ovarian stimulation, Gonadotrophins, GnRH antagonist - Infertility
Phase 4TerminatedInstituto Bernabeu152017-01-102019-08-19
Frozen-thawed Embryo Transfer in a Natural Cycle: hCG Triggering Versus LH Home Test
Human chorionic gonadotropin, Home ovulation test - Infertility
Phase 4TerminatedTampere University Hospital622017-01-012024-08-22
Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles
Progesterone 25 MG subcutaneous, Micronized progesterone 200 MG, recombinant FSH - Infertility, In Vitro Fertilization
Phase 4TerminatedAndros Day Surgery Clinic602016-12-202020-01-10
Type of Gonadotropin and Embryo Kinetics of Development
Corifollitropin alfa - Infertility
Phase 4TerminatedIVI Madrid2012015-04-012022-08-11
Corifollitropin Alfa Versus Daily rFSH in the Controlled Ovarian Stimulation of Poor Responders
Corifollitropin alfa - Infertility
Phase 4TerminatedVida Recoletas Sevilla262014-09-012016-01-18
Low-dose Gonal-f® in Ovulation Induction
Gonal-f® - Infertility, Monofollicular Development
Phase 4TerminatedMerck KGaA, Darmstadt, Germany242013-07-012016-08-11
Study of Dual Trigger Ovulation in Oocyte Donors
HCG, Lupron Trigger, Dual Trigger - Infertility
Phase 4TerminatedWeill Medical College of Cornell University262013-01-012019-06-26
NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization Cycles
Contraceptives, Oral, Contraceptive, Vaginal ring - Infertility
Phase 4TerminatedClinique Ovo72012-07-012015-07-27
Delayed Start to Ovarian Stimulation
Ganirelix acetate - Diminished Ovarian Reserve, Infertility
Phase 4TerminatedUniversity of California, San Francisco302012-05-012021-06-15
The Luveris In Vitro Fertilization Trial
Luveris fixed dose, Luveris increasing dose - Infertility, Hypothalamic Amenorrhea
Phase 4TerminatedUniversity Reproductive Associates142009-04-012018-08-07
Metformin in Patients With PCOS and Predictors of Poor Ovarian Response Ongoing In-vitro Fertilization
Metformin, Placebo - Infertility, PCOS
Phase 4TerminatedUniversity Magna Graecia882009-01-012011-05-24
The Effect of Acupuncture on Pregnancy Rates in Women Undergoing Embryo Transfer
Active acupuncture, Sham acupuncture - Pregnancy
Phase 4TerminatedOttawa Fertility Centre302008-08-012015-07-09
EXpression PRofile Endometrium Samples Study
Gonal -f® [r-hFSH], Ovitrelle® [r-hCG alfa], Gonadotropin-releasing hormone (GnRH) Agonist - In Vitro Fertilization
Phase 4TerminatedMerck KGaA, Darmstadt, Germany272008-08-012013-12-27
Protocols for Improved in Vitro Fertilization (IVF) Outcomes
Microflare protocol for IVF, Antagonist protocol for IVF, Demi-halt protocol for IVF - Infertility
Phase 4TerminatedUniversity of California, San Francisco22006-06-012011-10-06
Duration of GnRH-analogue Downregulation and Pregnancy Rates
Duration of GnRH agonist downregulation - Infertility
Phase 4TerminatedAristotle University Of Thessaloniki3002006-05-012016-02-12

Narrower conditions

Hyperprolactinemia (1)  ·  Infertility, Female (1)  ·  Ovarian Hyperstimulation Syndrome (1)

Broader conditions

Genital Diseases (19)  ·  Urogenital Diseases (19)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases, Female (2)  ·  Adnexal Diseases (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Gonadal Disorders (1)  ·  Hyperpituitarism (1)  ·  Hypothalamic Diseases (1)  ·  Nervous System Diseases (1)  ·  Ovarian Diseases (1)

Interventions

follitropin alfa (3)  ·  Chorionic Gonadotropin (2)  ·  Glycoprotein Hormones, alpha Subunit (2)  ·  Gonadotropin-Releasing Hormone (2)  ·  follicle stimulating hormone, human, with HCG C-terminal peptide (2)  ·  Contraceptive Agents (1)  ·  Contraceptive Devices, Female (1)  ·  Contraceptives, Oral (1)  ·  Crinone (1)  ·  Desogestrel (1)  ·  Dydrogesterone (1)  ·  Gonadotropins (1)  ·  Ibuprofen (1)  ·  Injections, Subcutaneous (1)  ·  Ketorolac (1)

Sponsors

Merck KGaA, Darmstadt, Germany (5)  ·  University of California, San Francisco (2)  ·  Andros Day Surgery Clinic (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Clinique Ovo (1)  ·  IVI Madrid (1)  ·  Instituto Bernabeu (1)  ·  Madigan Army Medical Center (1)  ·  Ottawa Fertility Centre (1)  ·  Tampere University Hospital (1)  ·  University Magna Graecia (1)  ·  University Reproductive Associates (1)  ·  Vida Recoletas Sevilla (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (5)  ·  Italy (4)  ·  Canada (3)  ·  Spain (3)  ·  France (2)  ·  China (1)  ·  Denmark (1)  ·  Finland (1)  ·  Greece (1)  ·  Ireland (1)  ·  Norway (1)  ·  Portugal (1)  ·  United Kingdom (1)

Top investigators

Adolfo Allegra, MD (1)  ·  Arthur Leader, MD (1)  ·  Basil C Tarlatzis, MD PhD (1)  ·  Bruce Pier (1)  ·  Doron Shmorgun, MD (1)  ·  Fulvio Zullo, MD (1)  ·  Helena Tinkanen (1)  ·  Jacques Kadoch, MD (1)  ·  Juan C Castillo, Md. PhD. (1)  ·  Marcelle I Cedars, MD (1)  ·  Mitchell Rosen, MD (1)  ·  Stefano Palomba, MD (1)

Results publications

PMID 15155606, PMID 19684043, PMID 21828117, PMID 21892335, PMID 21917254, PMID 23352098

NIH funding

2016 (1)